Ameliorating effect of AEA on gastric hypersensitivity.

<p>AEA1, but not AEA2, reduced gastric hypersensitivity in FD rats. AEA1 decreased EMG responses to GD at 40, 60 and 80mmHg(AEA1 vs. Baseline, *p<0.01). (B) Sham-EA had no effect on gastric hypersensitivity in FD rats. (C) AEA1 could reduce the behavior responses in FD rats (*p<0.01, ^#p = 0.018). (D) AEA1 had no effect on gastric sensitivity in control rats.</p

AEA1 did not alter gastric emptying.

<p>There was no significant difference in gastric emptying among control group, FD+ AEA1 group and FD+sham-EA group.</p

Improvement of sympathovagal balance by AEA1.

<p>AEA1 increased the HF component in FD rats (*p<0.01). (B) AEA1 decreased the LF/HF ratio in FD rats (*p<0.01). A in the above figures meant the baseline of HF component or LF/HF ratio. B and C meant the data in the first 15min period and the second 15 min period during AEA1, respectively.</p

Sympathovagal imbalance in FD rats.

<p>The low HF component was found in FD rats (*p = 0.016). (B) The high LF/HF ratio was found in FD rats(^#p = 0.017).</p

Naloxone did not block the effect of AEA1.

<p>Naloxone did not influence the EMG responses to GD. AEA1 decreased the EMG responses when naloxone was performed intraperitoneally 20min before AEA1(*p = 0.01).</p